Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

UMAMA GORSI

Allopathic & Osteopathic Physicians Internal Medicine Advanced Heart Failure and Transplant Cardiology

NPI
1679914022
CMS profile
1037443
Location
CINCINNATI, OH

General Payments · PY2018–2024

$17,754.71

  • Reported across 195 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$4,320.16

33 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,804.26 25
Consulting Fee $1,400.00 1
Travel and Lodging $1,095.32 5
Education $20.58 2

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
E.R. Squibb & Sons, L.L.C. $1,649.31 14
CVRx Inc. $1,426.44 7
NOVARTIS PHARMACEUTICALS CORPORATION $539.43 5
PROCYRION, INC. $162.89 1
ABIOMED $150.00 1
Abbott Laboratories $128.76 2
GENZYME CORPORATION $128.34 1
AngioDynamics, Inc. $114.29 1
Kiniksa Pharmaceuticals International, plc $20.70 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $817.69 21
PY2019 $2,710.19 51
PY2020 $2,632.57 29
PY2021 $185.57 1
PY2022 $1,729.00 13
PY2023 $5,359.53 47
PY2024 $4,320.16 33

Payment records · PY2024 (33)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $26.38 08/26/2024 Food and Beverage Undisputed 01/23/2026 1125193351 CMS
Abbott Laboratories $102.38 10/17/2024 Food and Beverage Undisputed 01/23/2026 1125193355 CMS
ABIOMED $150.00 07/08/2024 Food and Beverage Undisputed 01/23/2026 1142241257 CMS
AngioDynamics, Inc. $114.29 09/03/2024 Food and Beverage Undisputed 01/23/2026 1095076848 CMS
CVRx, Inc. $312.20 05/31/2024 Travel and Lodging Undisputed 01/23/2026 1123810324 CMS
CVRx, Inc. $304.75 05/31/2024 Travel and Lodging Undisputed 01/23/2026 1124769742 CMS
CVRx, Inc. $294.52 05/31/2024 Travel and Lodging Undisputed 01/23/2026 1124769744 CMS
CVRx, Inc. $260.34 05/31/2024 Food and Beverage Undisputed 01/23/2026 1124769746 CMS
CVRx, Inc. $93.89 06/01/2024 Food and Beverage Undisputed 01/23/2026 1124769748 CMS
CVRx, Inc. $146.62 06/01/2024 Food and Beverage Undisputed 01/23/2026 1124769750 CMS
CVRx, Inc. $14.12 09/19/2024 Food and Beverage Undisputed 01/23/2026 1128562702 CMS
E.R. Squibb & Sons, L.L.C. $119.49 02/21/2024 Food and Beverage Undisputed 01/23/2026 1101252616 CMS
E.R. Squibb & Sons, L.L.C. $2.98 03/08/2024 Food and Beverage Undisputed 01/23/2026 1101252618 CMS
E.R. Squibb & Sons, L.L.C. $1,400.00 03/26/2024 Consulting Fee Undisputed 01/23/2026 1101252614 CMS
E.R. Squibb & Sons, L.L.C. $3.08 03/28/2024 Food and Beverage Undisputed 01/23/2026 1101252620 CMS
E.R. Squibb & Sons, L.L.C. $1.02 03/28/2024 Food and Beverage Undisputed 01/23/2026 1101252622 CMS
E.R. Squibb & Sons, L.L.C. $3.29 04/11/2024 Food and Beverage Undisputed 01/23/2026 1101252632 CMS
E.R. Squibb & Sons, L.L.C. $1.11 04/11/2024 Food and Beverage Undisputed 01/23/2026 1101252634 CMS
E.R. Squibb & Sons, L.L.C. $78.94 04/25/2024 Food and Beverage Undisputed 01/23/2026 1101252628 CMS
E.R. Squibb & Sons, L.L.C. $10.29 05/14/2024 Education Undisputed 01/23/2026 1101252636 CMS
E.R. Squibb & Sons, L.L.C. $10.29 05/14/2024 Education Undisputed 01/23/2026 1101252638 CMS
E.R. Squibb & Sons, L.L.C. $2.27 08/15/2024 Food and Beverage Undisputed 01/23/2026 1101252654 CMS
E.R. Squibb & Sons, L.L.C. $1.40 08/27/2024 Food and Beverage Undisputed 01/23/2026 1101252650 CMS
E.R. Squibb & Sons, L.L.C. $0.83 08/27/2024 Food and Beverage Undisputed 01/23/2026 1101252652 CMS
E.R. Squibb & Sons, L.L.C. $14.32 11/06/2024 Food and Beverage Undisputed 01/23/2026 1101252688 CMS
GENZYME CORPORATION $128.34 07/30/2024 Food and Beverage Undisputed 01/23/2026 1139944737 CMS
Kiniksa Pharmaceuticals International, plc $20.70 11/18/2024 Food and Beverage Undisputed 01/23/2026 1154885514 CMS
Novartis Pharmaceuticals Corporation $140.00 04/19/2024 Food and Beverage Undisputed 01/23/2026 1086800997 CMS
Novartis Pharmaceuticals Corporation $12.50 04/20/2024 Travel and Lodging Undisputed 01/23/2026 1086800993 CMS
Novartis Pharmaceuticals Corporation $171.35 04/20/2024 Travel and Lodging Undisputed 01/23/2026 1086800995 CMS
Novartis Pharmaceuticals Corporation $203.81 04/20/2024 Food and Beverage Undisputed 01/23/2026 1086800999 CMS
Novartis Pharmaceuticals Corporation $11.77 05/30/2024 Food and Beverage Undisputed 01/23/2026 1086800991 CMS
PROCYRION, INC. $162.89 10/28/2024 Food and Beverage Undisputed 01/23/2026 1143646175 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.